AEGIR
AegirBio AB (publ)
Save
16.03M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical - Instruments & Supplies
Industry
AegirBio AB (publ), a diagnostic company, develops and commercializes tests to follow the dosage of biological drugs. The company focuses on therapeutic drug monitoring of biologic therapies in the multiple sclerosis, cancer, and autoimmune diseases. It offers moNATor, a first dose-monitoring laboratory test to test multiple sclerosis for healthcare professionals and patients; and Viraspec, a COVID-19 saliva test kit.
Similar securities
Based on sector and market capitalization
Report issue